NASDAQ · Health care

Black Hawk Acquisition Corp (BKHA)

At May 31, 2026 it held $0 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 15, 2026.

Price

$12.27

+0.66% on the day · September 25, 2026

52-week range $11.00 to $13.10

Market cap

$51M

What Black Hawk Acquisition Corp does

Black Hawk Acquisition Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker BKHA.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$915.5K	$1.3M	n/a	n/a
2024	n/a	-$576.1K	$1.9M	n/a	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around October 8, 2026.

Estimated from its filing rhythm: about 85 days after its last report of July 15, 2026, its usual gap. Not a date the company has announced. See the report calendar

Dividends

It paid out $51M in cash dividends, 3,837% of its net income.

Fiscal year	Per share	Paid out	Of profit
2025	n/a	$51M	3,837%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Black Hawk Acquisition Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 25, 2026
Form 425 filing 425
September 24, 2026
Material agreement 8-K
September 22, 2026
Other event 8-K
September 22, 2026
Securities offering prospectus 424B4
September 4, 2026
Merger registration (amended) S-4/A
August 26, 2026
Material agreement 8-K
August 25, 2026
Other event 8-K
August 3, 2026
Merger registration (amended) S-4/A
July 22, 2026
Other event 8-K
July 15, 2026
Quarterly report 10-Q · period to May 31, 2026Net income fell 83% to $88.9K.

Recent insider filings (Forms 3, 4 and 144): 6, the latest on April 26, 2024. Insider transactions on SEC

All filings on SEC EDGAR

Questions about BKHA

What does Black Hawk Acquisition Corp do?

Black Hawk Acquisition Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker BKHA.

Is Black Hawk Acquisition Corp profitable?

Yes. Over the twelve months to May 31, 2026 it reported net income of $379.4K.

When did Black Hawk Acquisition Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 15, 2026. It covers the period to May 31, 2026. Its newest filing of any kind is the form 425 filing from September 25, 2026.

Similar companies

AMGN

Amgen Inc

GILD

Gilead Sciences, Inc.

Neurocrine Biosciences Inc

EXEL

Exelixis, Inc.

Compare BKHA with

Compare BKHA with any company

Follow BKHA

Get an email when Black Hawk Acquisition Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow BKHA: get an email when it files

Where the numbers come from

Financial figures are the values Black Hawk Acquisition Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.